Successful Imatinib Treatment of an Abdominal Compartment Syndrome due to Huge Gastrointestinal Stromal Tumour

Successful Imatinib Treatment of an Abdominal Compartment Syndrome due to Huge Gastrointestinal Stromal Tumour

Gastrointestinal stromal tumours (GISTs) are the most common digestive mesenchymal tumours, whose prognosis has been revolutionised by targeted therapies such as oral imatinib. Abdomen compartment syndrome (ACS) is associated with mortality superior to 50% in adults. ACS has never been reported to d...

Full description

Bibliographic Details
Main Authors: Alexandre Bertucci, Jérôme Guiramand, Lena Mescam, Audrey Monneur, Magali Bisbal, Laurent Chow-Chine, Antoine Sannini, Delphine Perrot, Valéria De Luca, Djamel Mokart, François Bertucci
Format: Article
Language:English
Published: Karger Publishers 2019-08-01
Series:Case Reports in Oncology
Subjects:
Abdominal compartment syndrome
GIST
Imatinib
Intensive care
Online Access:https://www.karger.com/Article/FullText/502338

Internet

https://www.karger.com/Article/FullText/502338

Similar Items